Industries > Pharma > Global Translational Regenerative Medicine Market Prospects 2018-2028

Global Translational Regenerative Medicine Market Prospects 2018-2028

Stem Cell Therapies, Tissue Engineered Products, Gene Therapies

PUBLISHED: 27 March 2018
PAGES: 306
PRODUCT CODE: PHA0296

Clear
WOOCS 2.2.1

The Global Translational Regenerative Medicine market is estimated to grow at a CAGR of 22.1% in the first half of the forecast period. Stem cell therapies accounted for the majority of the revenue in the market with an estimated market share of 56.0% in 2017.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new report you find 306-page report you will receive 109 tables and 67 figures – all unavailable elsewhere.

The 306-page report provides clear detailed insight into the Global Translational Regenerative Medicine market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

Global Translational Regenerative Medicine market forecasts from 2018-2028

• Global Translational Regenerative Medicine submarket forecasts from 2018-2028 covering:
• Stem Cell Therapies
• Tissue Engineered Products
• Gene Therapies

This study discusses the late-state clinical trials and pipeline as well as market drivers and restraints of each submarket.

• Translational Regenerative Medicine regional market forecasts from 2018-2028, covering:
• United States
• Europe
• Asia-Pacific
• Rest of the World

• Forecasts from 2018-2028 of the leading products in the Global Translational Regenerative Medicine market:
• Osteocel Plus
• Trinity ELITE
• TEMCELL /Prochymal
• Apligraf
• Dermagraft
• Epifix
• ReCell
• Neovasculgen
• Glybera (alipogene tiparvovec)
• IMLYGIC (talimogene laherparepvec)

Global Translational Regenerative Medicine Market Prospects 2018-2028

• Assessment of the leading companies in the Global Translational Regenerative Medicine market:
• Alphatec Spine
• Anterogen
• Athersys
• Avita Medical
• AxoGen
• Medipost
• Mesoblast
• NuVasive
• Ocata Therapeutics
• Organogenesis
• Pharmicell
• Regenerys
• TiGenix
• UniQure
• Vericel Corporation

• Information on current developments, current advancements and current key approvals in the field of translational regenerative medicine market.

SWOT and Porter’s Five Force analysis of the translational regenerative medicine market

Visiongain’s study is intended for anyone requiring commercial analyses for the Translational Regenerative Medicine Market and leading companies. You find data, trends and predictions.

Buy our report today Global Translational Regenerative Medicine Market Prospects 2018-2028: Stem Cell Therapies, Tissue Engineered Products, Gene Therapies.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Translational Regenerative Medicine Market Prospects 2018-2028


Download sample pages

Complete the form below to download your free sample pages for Global Translational Regenerative Medicine Market Prospects 2018-2028


Latest Pharma news

Visiongain Publishes Inspection Machine Market Report 2021-2031

Supervisory obligations in the healthcare industry to sustain compliance with good manufacturing practices, growing number of inspection frontiers in production lines, growing number of product evokes, rising dispersion of automated inspection systems in the pharmaceutical & biotechnology industries, and technological advancement in inspection systems are the major aspects driving the growth of this market.

29 October 2020

READ

Visiongain Publishes Hydrophobic Interaction Chromatography Market Report 2021-2031

Global Hydrophobic Interaction Chromatography (HIC) is one of the most extensively used methods for splitting and cleansing proteins in their native state. HIC also proves to be quite useful in isolating protein complexes and in studying protein folding and unfolding.

29 October 2020

READ

Visiongain Publishes Hemostats and Sealants Market Report 2021-2031

Rise in the occurrences of chronic conditions of elderly population has boosted the growth of the Hemostats and Sealants market, globally. According to the Centres for Disease Control and Prevention (CDC) statistics, over 45% of American population suffers from at least one chronic condition needing critical care. Thus, these factors are impacting the market towards a positive growth.

29 October 2020

READ

Visiongain Publishes Healthcare Distribution Market Report 2021-2031

The high incidence and large economic crises of chronic disease are primarily driving the market growth, high investments in R&D activities and increasing launch of new rugs and medicines in the healthcare market is supporting the growth of the distribution market.

29 October 2020

READ

Categories

Category